Mettler-Toledo International, Inc. MTD
1,511.64
(7.51)
(0.49%)
as of 25 Sep
- Market cap
- $30.4B
- P/E
- 33.9×
Follow MTD
Indexes
indicate stock being part of an index
Mettler-Toledo International, Inc. (MTD) Return on assets
Mettler-Toledo International, Inc.'s return on assets over the twelve months to 30 June 2026 was 25.6%, up 0.6 percentage points from fiscal 2025 (25.0%). Over the past ten years it has ranged from 15.9% (fiscal 2017) to 26.2% (fiscal 2024); the current reading is higher than 73% of that period. That is above the Diagnostics & Research industry median of −6.71% and above the Healthcare sector median of −30.9%.
Return on assets, annual
Annual
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | 25.0% | (1.17) |
| FY2024 | 26.2% | 3.13 |
| FY2023 | 23.0% | (2.55) |
| FY2022 | 25.6% | 0.55 |
| FY2021 | 25.0% | 3.53 |
| FY2020 | 21.5% | 0.76 |
| FY2019 | 20.8% | 0.91 |
| FY2018 | 19.8% | 3.90 |
| FY2017 | 15.9% | (2.69) |
| FY2016 | 18.6% | 0.85 |
Against its own ten years
Low 15.9%
High 26.2%
Ten-year median
21.5%
Current reading's percentile
73
Return on assets against peers
| Company | Return on assets |
|---|---|
| IDXX IDEXX Laboratories, Inc. compare | 33.7% |
| MTD Mettler-Toledo International, Inc. | 25.6% |
| ILMN Illumina, Inc. compare | 13.0% |
| A Agilent Technologies, Inc. compare | 11.0% |
| DGX Quest Diagnostics Incorporated compare | 6.43% |
| LH Labcorp Holdings Inc. compare | 5.48% |
| IQV IQVIA Holdings Inc. compare | 4.70% |
| WAT Waters Corporation compare | 1.13% |
| GH Guardant Health, Inc. compare | −28.0% |
| Diagnostics & Research industry median | −6.71% |
| Healthcare sector median | −30.9% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on MTD
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement